Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C.

References

• Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014). Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clinical Infectious Diseases, 58(1), e1–e34. https://doi.org/10.1093/cid/cit665
   PubMed Web of Science ®Google Scholar
• Aberg, J. A., Tebas, P., Overton, E. T., Gupta, S. K., Sax, P. E., Landay, A., Falcon, R., Ryan, R., & De La Rosa, G. (2012). Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. AIDS Research and Human Retroviruses, 28(10), 1184–1195. https://doi.org/10.1089/aid.2011.0327
   PubMed Web of Science ®Google Scholar
• Adeyemi, O. (2007). Cardiovascular risk and risk management in HIV-infected patients. Topics in HIV Medicine, 15(5), 159–162.
   PubMedGoogle Scholar
• Adeyemi, O., Vibhakar, S., & Max, B. (2009). Are we meeting the American diabetes association goals for HIV-infected patients with diabetes mellitus? Clinical Infectious Diseases, 49(5), 799–802. https://doi.org/10.1086/605286
   PubMed Web of Science ®Google Scholar
• Armah, K. A., McGinnis, K., Baker, J., Gibert, C., Butt, A. A., Bryant, K. J., Goetz, M., Tracy, R., Oursler, K. K., Rimland, D., Crothers, K., Rodriguez-Barradas, M., Crystal, S., Gordon, A., Kraemer, K., Brown, S., Gerschenson, M., Leaf, D. A., Deeks, S. G., … Freiberg, M. (2012). HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clinical Infectious Diseases, 55(1), 126–136. https://doi.org/10.1093/cid/cis406
   PubMed Web of Science ®Google Scholar
• Association, A. D. (2017). Standards of medical care in diabetes-2017. Diabetes Care, 40, S48–S56. https://doi.org/10.2337/dc17-S009
   Web of Science ®Google Scholar
• Boyd, M. A. (2009). Improvements in antiretroviral therapy outcomes over calendar time. Current Opinion in HIV and AIDS, 4(3), 194–199. https://doi.org/10.1097/COH.0b013e328329fc8d
   PubMed Web of Science ®Google Scholar
• Brambilla, A. M., Novati, R., Calori, G., Meneghini, E., Vacchini, D., Luzi, L., Castagna, A., & Lazzarin, A. (2003). Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals. Aids (london, England), 17(13), 1993–1995. https://doi.org/10.1097/00002030-200309050-00022
   PubMed Web of Science ®Google Scholar
• Bury, J. E., Stroup, J. S., Stephens, J. R., & Baker, D. L. (2007). Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus. Baylor University Medical Center Proceedings, 20(2), 118–123. https://doi.org/10.1080/08998280.2007.11928265
   PubMedGoogle Scholar
• Ciancio, A., Bosio, R., Bo, S., Pellegrini, M., Sacco, M., Vogliotti, E., Fassio, G., Bianco Mauthe Degerfeld, A. G. F., Gallo, M., Giordanino, C., Terzi di Bergamo, L., Ribaldone, D., Bugianesi, E., Smedile, A., Rizzetto, M., & Saracco, G. M. (2018). Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents. Journal of Medical Virology, 90(2), 320–327. https://doi.org/10.1002/jmv.24954
   PubMed Web of Science ®Google Scholar
• Colasanti, J., Galaviz, K. I., Christina Mehta, C., Palar, K., Schneider, M. F., Tien, P., Adimora, A. A., Alcaide, M., Cohen, M. H., Gustafson, D., Karim, R., Merenstein, D., Sharma, A., Wingood, G., Marconi, V. C., Ofotokun, I., & Ali, M. K. (2018). Room for improvement: The HIV-diabetes care continuum over 15 years in the womens interagency HIV study. Open Forum Infectious Diseases, 5(6), Article ofy121. https://doi.org/10.1093/ofid/ofy121
   Web of Science ®Google Scholar
• Davies, M. L., Johnson, M. D., Brown, J. N., Bryan, W. E., & Townsend, M. L. (2015). Predictors of glycaemic control among HIV-positive veterans with diabetes. International Journal of STD & AIDS, 26(4), 262–267. https://doi.org/10.1177/0956462414535207
   PubMed Web of Science ®Google Scholar
• Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013). The end of AIDS: HIV infection as a chronic disease. The Lancet, 382(9903), 1525–1533. https://doi.org/10.1016/s0140-6736(13)61809-7
   PubMed Web of Science ®Google Scholar
• De Wit, S., Sabin, C. A., Weber, R., Worm, S. W., Reiss, P., Cazanave, C., El-Sadr, W., Monforte, A. d., Fontas, E., Law, M. G., Friis-Moller, N., & Phillips, A. (2008). Incidence and risk factors for new-onset diabetes in HIV-infected patients: The data collection on adverse events of Anti-HIV Drugs (D:A:D) study. Diabetes Care, 31(6), 1224–1229. https://doi.org/10.2337/dc07-2013
   PubMed Web of Science ®Google Scholar
• District of Columbia HIV/AIDS, Hepatitis, STD, TB, Hepatitis, STD, and TB Administration (HAHSTA) Annual Epidemiology and surveillance report: Data through December 2018. https://dchealth.dc.gov/node/1424881
   Google Scholar
• Duncan, A. D., Goff, L. M., & Peters, B. S. (2018). Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study. PLoS One, 13(3), Article e0194199. https://doi.org/10.1371/journal.pone.0194199
   Web of Science ®Google Scholar
• Duong, M., Petit, J. M., Piroth, L., Grappin, M., Buisson, M., Chavanet, P., Hillon, P., & Portier, H. (2001). Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 27(3), 245–250. https://doi.org/10.1097/00126334-200107010-00005
   PubMed Web of Science ®Google Scholar
• Greenberg, A. E., Hays, H., Castel, A. D., Subramanian, T., Happ, L. P., Jaurretche, M., Binkley, J., Kalmin, M. M., Wood, K., & Hart, R. (2016). Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: Technical challenges and innovative solutions. Journal of the American Medical Informatics Association, 23(3), 635–643. https://doi.org/10.1093/jamia/ocv176
   PubMed Web of Science ®Google Scholar
• Guaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., & Palella, F. (2011). Premature age-related comorbidities among HIV-infected persons compared with the general population. Clinical Infectious Diseases, 53(11), 1120–1126. https://doi.org/10.1093/cid/cir627
   PubMed Web of Science ®Google Scholar
• Han, J. H., Crane, H. M., Bellamy, S. L., Frank, I., Cardillo, S., & Bisson, G. P. (2012). HIV infection and glycemic response to newly initiated diabetic medical therapy. Aids (London, England), 26(16), 2087–2095. https://doi.org/10.1097/QAD.0b013e328359a8e5
   PubMed Web of Science ®Google Scholar
• Hasse, B., Tarr, P. E., Marques-Vidal, P., Waeber, G., Preisig, M., Mooser, V., Valeri, F., Djalali, S., Andri, R., Bernasconi, E., Calmy, A., Cavassini, M., Vernazza, P., Battegay, M., Weber, R., Senn, O., Vollenweider, P., Ledergerber, B., Aubert, V., … Marco, Z. (2015). Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population. Open Forum Infectious Diseases, 2(3), Article ofv108. https://doi.org/10.1093/ofid/ofv108
   Web of Science ®Google Scholar
• Hernandez-Romieu, A. C., Garg, S., Rosenberg, E. S., Thompson-Paul, A. M., & Skarbinski, J. (2017). Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010. BMJ Open Diabetes Research & Care, 5(1), Article e000304. https://doi.org/10.1136/bmjdrc-2016-000304
   PubMed Web of Science ®Google Scholar
• Jain, M. K., Aragaki, C., Fischbach, L., Gibson, S., Arora, R., May, L., Vardhineni, K., & Lee, W. M. (2007). Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors. HIV Medicine, 8(8), 491–497. https://doi.org/10.1111/j.1468-1293.2007.00499.x
   PubMed Web of Science ®Google Scholar
• Justman, J. E., Benning, L., Danoff, A., Minkoff, H., Levine, A., Greenblatt, R. M., Weber, K., Piessens, E., Robison, E., & Anastos, K. (2003). Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 32(3), 298–302. https://doi.org/10.1097/00126334-200303010-00009
   PubMed Web of Science ®Google Scholar
• Kim, P. S., Woods, C., Georgoff, P., Crum, D., Rosenberg, A., Smith, M., & Hadigan, C. (2009). A1c underestimates glycemia in HIV infection. Diabetes Care, 32(9), 1591–1593. https://doi.org/10.2337/dc09-0177
   PubMed Web of Science ®Google Scholar
• Levy, M. E., Greenberg, A. E., Hart, R., Powers Happ, L., Hadigan, C., Castel, A., Benator, D., Kumar, P., Goldstein, D., Hardy, D., Parenti, D., Ruiz, M. E., D'Angelo, L., Rakhmanina, N., Rana, S., Doshi, S., Hebou, A., Fernandez, R., Abbott, S., … Masur, H. (2017). High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: Evolving health care needs of people aging with HIV in Washington, DC. HIV Medicine, 18(10), 724–735. https://doi.org/10.1111/hiv.12516
   PubMed Web of Science ®Google Scholar
• Lumpkin, M. M. (1997). Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus infection. FDA Public Health Advisory.
   Google Scholar
• Malek, W., Yager, J., Britt, N., Morse, C., Hecox, Z., Hoye-Simek, A., Sullivan, S., & Patel, N. (2017). Clinical outcomes associated with single tablet regimens: Relationship between antiretroviral therapy pill burden and control of concomitant Comorbidities among HIV-Infected Patients. J HIV Retrovirus, 3(1), 1–7. https://doi.org/10.21767/2471-9676.100032
   Google Scholar
• Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2016). Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 73(1), 39–46. https://doi.org/10.1097/qai.0000000000001014
   PubMed Web of Science ®Google Scholar
• Monroe, A. K., Chander, G., & Moore, R. D. (2011). Control of medical comorbidities in individuals with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 58(5), 458–462. https://doi.org/10.1097/QAI.0b013e31823801c4
   PubMed Web of Science ®Google Scholar
• Monroe, A. K., Fu, W., Zikusoka, M. N., Jacobson, L. P., Witt, M. D., Palella, F. J., Kingsley, L. A., Post, W. S., & Brown, T. T. (2015). Low-density lipoprotein cholesterol levels and statin treatment by HIV status among multicenter AIDS cohort study men. AIDS Research and Human Retroviruses, 31(6), 593–602. https://doi.org/10.1089/aid.2014.0126
   PubMed Web of Science ®Google Scholar
• Murata, H., Hruz, P. W., & Mueckler, M. (2002). Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. Aids (london, England), 16(6), 859–863. https://doi.org/10.1097/00002030-200204120-00005
   PubMed Web of Science ®Google Scholar
• Myerson, M., Poltavskiy, E., Armstrong, E. J., Kim, S., Sharp, V., & Bang, H. (2014). Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66(4), 370–377. https://doi.org/10.1097/qai.0000000000000168
   PubMed Web of Science ®Google Scholar
• Nichols, G. A., Hillier, T. A., Javor, K., & Brown, J. B. (2000). Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care, 23(3), 273–277. https://doi.org/10.2337/diacare.23.3.273
   PubMed Web of Science ®Google Scholar
• Overton, E. T., Tebas, P., Coate, B., Ryan, R., Perniciaro, A., Dayaram, Y. K., De La Rosa, G., & Baugh, B. P. (2016). Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: Results of an exploratory substudy of METABOLIK, a phase 4, randomized trial. HIV Clinical Trials, 17(2), 72–77. https://doi.org/10.1080/15284336.2016.1141468
   PubMed Web of Science ®Google Scholar
• Puhr, R., Petoumenos, K., Huang, R., Templeton, D. J., Woolley, I., Bloch, M., Russell, D., Law, M. G., & Cooper, D. A. (2019). Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: Insights from the Australian positive & Peers Longevity evaluation study. HIV Medicine, 20(2), 121–130. https://doi.org/10.1111/hiv.12689
   PubMed Web of Science ®Google Scholar
• Reinsch, N., Neuhaus, K., Esser, S., Potthoff, A., Hower, M., Mostardt, S., Neumann, A., Brockmeyer, N. H., Gelbrich, G., Erbel, R., & Neumann, T. (2012). Are HIV patients undertreated? Cardiovascular risk factors in HIV: Results of the HIV-HEART study. European Journal of Preventive Cardiology, 19(2), 267–274. https://doi.org/10.1177/1741826711398431
   PubMed Web of Science ®Google Scholar
• Rife, K., Lyman, A., LeClerc-Kamieniecki, S., Falck-Ytter, C., Pascuzzi, K., Burant, C. J., & Falck-Ytter, Y. (2019). Significant HbA1c lowering in patients achieving a hepatitis C virus cure. Federal Practitioner, 36(Suppl 2), S26–s32.
   PubMedGoogle Scholar
• Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., Justice, A., Kirk, G., Klein, M. B., Korthuis, P. T., Martin, J., Napravnik, S., Rourke, S. B., Sterling, T. R., Silverberg, M. J., … Okulicz, J. F. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8(12), Article e81355. https://doi.org/10.1371/journal.pone.0081355
   Web of Science ®Google Scholar
• Satlin, M. J., Hoover, D. R., & Glesby, M. J. (2011). Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines. AIDS Patient Care and STDs, 25(1), 5–12. https://doi.org/10.1089/apc.2010.0237
   PubMed Web of Science ®Google Scholar
• Sico, J. J., Chang, C.-C. H., So-Armah, K., Justice, A. C., Hylek, E., Skanderson, M., McGinnis, K., Kuller, L. H., Kraemer, K. L., Rimland, D., Bidwell Goetz, M., Butt, A. A., Rodriguez-Barradas, M. C., Gibert, C., Leaf, D., Brown, S. T., Samet, J., Kazis, L., Bryant, K., … Freiberg, M. S. (2015). HIV status and the risk of ischemic stroke among men. Neurology, 84(19), 1933–1940. https://doi.org/10.1212/wnl.0000000000001560
   PubMed Web of Science ®Google Scholar
• Sobieszczyk, M. E., Hoover, D. R., Anastos, K., Mulligan, K., Tan, T., Shi, Q., Gao, W., Hyman, C., Cohen, M. H., Cole, S. R., Plankey, M. W., Levine, A. M., & Justman, J. (2008). Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the women's interagency HIV study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(3), 272–280. https://doi.org/10.1097/QAI.0b013e31817af461
   PubMed Web of Science ®Google Scholar
• Visnegarwala, F., Chen, L., Raghavan, S., & Tedaldi, E. (2005). Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. Journal of Infection, 50(4), 331–337. https://doi.org/10.1016/j.jinf.2004.06.001
   PubMed Web of Science ®Google Scholar
• Walli, R. H. O., Michl, G. M., Demant, T., Jäger, H., Dieterle, C., Bogner, J. R., Landgraf, R., & Goebel, F. D. (1998). Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. Aids (London, England), 12(15), F167–F173. https://doi.org/10.1097/00002030-199815000-00001
   PubMed Web of Science ®Google Scholar
• Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., & Wagenknecht, L. (2011). Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care, 34(7), 1481–1486. https://doi.org/10.2337/dc10-2415
   PubMed Web of Science ®Google Scholar
• Wong, C., Gange, S. J., Buchacz, K., Moore, R. D., Justice, A. C., Horberg, M. A., Gill, M. J., Koethe, J. R., Rebeiro, P. F., Silverberg, M. J., Palella, F. J., Patel, P., Kitahata, M. M., Crane, H. M., Abraham, A. G., Samji, H., Napravnik, S., Ahmed, T., Thorne, J. E., … Althoff, K. N. (2017). First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013. Clinical Infectious Diseases, 64(4), 459–467. https://doi.org/10.1093/cid/ciw804
   PubMed Web of Science ®Google Scholar
• Zuniga, J., Nguyen, M. L., & Holstad, M. (2016). Predictors of dual control of HIV and diabetes. AIDS Care, 28(9), 1124–1127. https://doi.org/10.1080/09540121.2016.1139667
   PubMed Web of Science ®Google Scholar